# Page 1
Administrative approval for the purchase of medicines in accordance with the grants available under the Epidemiology, Cholera Control, Epidemiology and District Medical Officer programmes.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: Purchase-2019/ PR No.153/ Health-8
New Mantralaya, Gokuldas Tejpal Hospital Compound
Complex Building, 10th Floor, Mumbai 400001
Date of Birth: March 2, 2020
Reference 1) Letter from Joint Director, Health Services, Directorate of Health Services, Mumbai No. SASAMASE/ EPA/ DRUG PURCHASE/ ADMINISTRATIONAL ACCEPTATION/ Cell- 58/13426-32/ D. 1.8.2019.
(ii) Government Resolution, Public Health Department, No. Purchase-2016/ PR No.240/ Health-8, dated 26.07.2017.
3) Letter from Joint Director, Directorate of Health Services, Pune vide No. SASAMASE/ EPA/ 2019-20/ Purchase of Epidemiological Drugs/ Attendant Issues/ Cell- 58/2880-82, dated 26.2.2020.
The proposal-
The Joint Director, Directorate of Health Services, Mumbai vide order dated 1.8.2019 vide Head No. In the head of accounts 22104286, 22100629, 2210208, 22100101, the budget provision for the financial year 2019-20 is Rs. 10,66,80, 000/- and at present, the account contribution on BDS system is Rs. 6,40,08, 000/- and 60% of the disbursed amount is Rs. A proposal for an amount of Rs 1,53,96, 292/- has been submitted to the Government for approval. The proposal is awaiting the government's approval.
Government's decision
The Joint Director, Directorate of Health Services, Mumbai has released a grant of Rs. 1,53,96, 292/- (Rs. Administrative approval is being granted for the purchase of medicines for an amount of one crore fifty-three lakh fifty-six thousand two hundred and fifty two only) subject to the following conditions.
# Page 2
Government Resolution No.Purchase-2019/ PR No. 153/ Health-8 Statement
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. no | Drug Name                         | DHO Consolida ted Qty                    | CS Consolida  |  te Qty  | DH+CS Demand Total | Rate Rs. | DHO total Conslidat ed Quantity | As per Availabl e Grant WBD Quantity | Approxima te total Amount |
| 1      | Ciprofloxa Tab                    |  250mg                                   | 4429831       | 31505667 | 35935498           | 0.745    | 4429831                         | 2000000                              | 1490000                   |
| 2      | Doxycycline Cap 100 mg            | 22258450                                 | 7901619       | 30160069 | 0.674              | 22258450 | 1000000                         | 674000                               |
| 3      | Norfloxacin Tab 400 mg            | 16155660                                 | 5912913       | 22068573 | 1.2314             | 16155660 | 1007200                         | 1361856                              |
| 4      | Oral Rehydration                  |  Salt Powder WHO Formula 20.5 gms Sachet | 27108690      | 7260932  | 34369622           | 2.2      | 27108690                        | 3000000                              | 6600000                   |
| 5      | Ringer Lactate 1..V 500 ml Bottle | 1447605                                  | 2939582       | 4387187  | 13.89              | 1447605  | 160000                          | 2222400                              |
| 6      | Metronidazole Tab 200 mg          | 34942700                                 | 15933091      | 50875791 | 1.351              | 34942700 | 2131754                         | 2880000                              |
| 7      | Cefotoxime Inj 1 gm vial          | 1017944                                  | 2715192       | 3733136  | 11.49              | 1017944  | 9400                            | 108006                               |
| 8      | Secinidiazole Tab                 |  gm 93.1                                 | 636840        | 125055   | 761895             | 10.35    | 47600                           | 5800                                 | 60030                     |
| total  | 1,53,96,292/                      |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Conditions:
1) The requirement/ demand for the purchase of the said medicine should be ascertained.
After that, the purchase process will begin.
2) To ensure that the specifications for the purchase of this medicine are as per the requirement and up-to-date
Technical specifications of the items to be purchased
(Should be as per the specifications approved by the Technical Committee/ Officers. As well as the technical
Technical specification in such a way that it will benefit any particular company.
Be sure it is not prepared. After that, you need to buy them.
Government Resolution, Department of Industry, Energy and Labour, No. 2014/ No. 82/ Part-||/
Industries- 4 Government Departments notified as on 01.12.2016
Revised Manual of Procedure for Office Purchases to be made
The procurement process should be carried out as per the provisions.
4) The rates of the proposed procurement are estimated at the time of granting administrative approval. The GEM Portal,
The National Pharmaceutical Pricing Authority (NPPA)
Minimum rates available should be taken into account as well as the relevant factors at the Haffkine Institute.
Estimated prices taking into account the minimum price received in the tender if purchased.
# Page 3
Government Decision No. 2019/ PR No. 153/ Health-8 should be considered as the rate and accordingly the tenderers should be recorded as the estimated rate in respect of medicines, medicines, materials and equipment and the rate should be fixed after the procurement process. It should be ensured that the price is less than the market price and not more than the rate at which the supplier has supplied the item to other places.
5) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
6) It should be ensured that after the supply of the items to be purchased, these items will not be left unused and they will be used within the stipulated time.
7) The expenditure should be met from the budgetary grants sanctioned for the financial year 2019-2020 under the head of Accounts No. 22104286, 22100629, 20100208, 22100101.
8) It should be ensured that there is no duplication of the purchase of these medicines and pharmaceutical materials.
9) The Central Vigilance Commission (CVC) guidelines should be strictly followed while carrying out the entire procurement process.
The conditions set out in Annexure to Regulation No. 30/2013/ Regulations, Part-II, dated 17.04.2015, to the Financial Powers Rules, 1978, Part-I, Sub-Division-II, No. 4, Rule No. 7 in front of Column No. 6 should be complied with.
11) Action should be taken as per the provisions of the Government Resolution dated 26.07.2017.
Full responsibility for fulfilling the conditions mentioned in the above sequence 1 to 11.
The programme will be led by the Director of Health Services.
Government Resolution, Department of Finance, No.VYPR-2013/ P.S. 30/2013/ Regulations, Part-II,
The Financial Powers Rules, 1978, Part-I in Annexure dated 17.04.2015,
Sub-Division-II No. 4, Rule No. 7 in front of column No. 6
The proposal has been accepted.
# Page 4
Government Resolution No.Procurement-2019/ PR No. 153/ Health-8